UmbriaExplore our travel guides. Share your stories, tips and questions on Reddit.
Fast movers • Alerts • Momentum
10% OFF with SAVE10
Charts • Watchlists • Multi-broker tools
Built for active traders
Biotech catalyst, news and analysis PDUFA tracker
Biotech catalyst, news and analysis PDUFA tracker
A larger order book and new partners expand the opportunity. Delivery, cash consumption and new shares will determine what reaches shareholders.
Get every Merlintrader report in real time on Telegram: join @merlintraderpub_com.
The August 6 outlook calls for sequential Q3 revenue growth and lower cash use through the second half. The next report must show progress on both. A specific earnings-release date is not established by the cited announcements; military-exercise invitations extend through March 2027 and do not guarantee procurement awards. Source
First-half 2026 cash burn, using operating outflow plus capex, was $21.290 million. The same period included approximately $17.8 million of gross ATM share sales. June liquidity reflects financing as well as business performance. Source Source
The constructive case starts with a real delivery business. Palladyne reported $24.6 million of backlog at June 30, 2026, and approximately $13 million of new awards during the quarter, against quarterly revenue of $5.783 million. Management reiterated 2026 revenue guidance of $24–27 million on August 6. That gives the company work to execute rather than a thesis resting entirely on demonstrations. The next improvement would be a combination of deliveries, repeat orders and lower cash consumption as the enlarged business absorbs its operating costs. Source Source
The adverse case is a timing mismatch. Staff, equipment and development expenditures are paid before customers accept systems or expand orders. Delayed procurement or integration then pushes revenue out while expenses continue. At June 30, 2026, the company had $43.746 million of cash and marketable securities, but its historical first-half burn rate implies only about 12.3 months of static coverage. That calculation is a sensitivity, not management’s forecast of the date cash will run out. Source
The constructive case starts with a real delivery business. Palladyne reported $24.6 million of backlog at June 30, 2026, and approximately $13 million of new awards during the quarter, against quarterly revenue of $5.783 million. Management reiterated 2026 revenue guidance of $24–27 million on August 6. That gives the company work to execute rather than a thesis resting entirely on demonstrations. The next improvement would be a combination of deliveries, repeat orders and lower cash consumption as the enlarged business absorbs its operating costs. Source Source
The partners plan industrial-robot integration and customer validation. The release gives no quantified purchase commitment. Source
SwarmOS and Underdog are to be integrated and demonstrated, subject to necessary government approvals. Source
Palladyne extends its autonomy software toward Orkid aircraft. The announcement does not give a contract value. Source
June-quarter revenue is $5.783 million and backlog $24.6 million. Management reiterates 2026 revenue of $24–27 million and cash burn of $32–36 million. Source
The full deep dive has the answer’s building blocks: cash, dilution, catalysts and risks, every figure sourced.
Free. No signup. You decide, we don’t recommend.
The constructive case starts with a real delivery business. Palladyne reported $24.6 million of backlog at June 30, 2026, and approximately $13 million of new awards during the quarter, against quarterly revenue of $5.783 million. Management reiterated 2026 revenue guidance of $24–27 million on August 6. That gives the company work to execute rather than a thesis resting entirely on demonstrations. The next improvement would be a combination of deliveries, repeat orders and lower cash consumption as the enlarged business absorbs its operating costs. Source Source
For the year ending December 31, 2026, the revenue guidance requires a calculated $14.679–17.679 million in second-half sales after the first half’s $9.321 million. That is a meaningful acceleration, and the favorable case is stronger if the increase arrives across consecutive quarters instead of being concentrated in a late shipment. A growing contribution from software product sales would add evidence that the technology can generate revenue beyond customer-funded development and the businesses acquired in November 2025. Source Source
FANUC America, NORDA Dynamics and Orkid create routes to potential customers; they do not determine the revenue outcome by themselves. A paid deployment or a follow-on contract would carry more financial weight than another integration announcement. The bullish interpretation also needs the improvement to reach existing shareholders: slower dilution and lower consumption of cash would support that conclusion. These are operating conditions, not a price objective.
The central case is an expanding defense and industrial supplier whose economics remain immature. For the six months ended June 30, 2026, operating cash outflow plus capital expenditure totaled a calculated $21.290 million. Revenue can grow quickly from a small base while the organization continues to consume substantial cash. Engineering, manufacturing, business development and software investment compete for the same liquidity. Source
In this scenario the backlog supports more deliveries, partnerships progress at different speeds, and software monetization remains gradual. Equity issuance continues to provide flexibility. That can sustain the business without producing the same rate of improvement in revenue or cash per share. The June-quarter balance sheet offers time to execute, but it does not remove the need to compare each subsequent capital raise with the commercial progress it finances.
The base case would be confirmed by a reasonable revenue increase accompanied by continued losses, uneven working-capital movements and additional share issuance. It would improve if cash usage declines without cutting the activities required to deliver contracted work. It would weaken if the annual revenue ambition becomes increasingly dependent on orders that have not yet turned into enforceable customer commitments.
The adverse case is a timing mismatch. Staff, equipment and development expenditures are paid before customers accept systems or expand orders. Delayed procurement or integration then pushes revenue out while expenses continue. At June 30, 2026, the company had $43.746 million of cash and marketable securities, but its historical first-half burn rate implies only about 12.3 months of static coverage. That calculation is a sensitivity, not management’s forecast of the date cash will run out. Source
A second risk is that the market treats collaborations as large orders and values the group as a mature software business. The June 2026 report explicitly states that software product sales had not yet produced revenue. The company does earn money through development contracts, hardware and engineering; those activities have different margins, delivery risks and capital requirements. Disappointment can therefore occur even if the technology works as described. Source
The negative case strengthens if cash consumption fails to fall, backlog conversion slows, or new equity becomes the main reason liquidity remains stable. It would be contradicted by repeat commercial adoption, a durable improvement in cash flow and growth that comfortably exceeds the increase in shares. Short positioning can amplify the response to either outcome, but it does not settle which outcome is more likely.
This reading changes when operating evidence changes. Partnership names and share-price moves alone do not settle the commercial or funding questions.
These are observations that would weaken the interpretation, not forecasts of inevitable events.
Palladyne AI combines autonomy software with avionics, engineering and precision manufacturing. The June 30, 2026 report describes Palladyne IQ for industrial robots and SwarmOS/Palladyne Pilot for autonomous systems. In practical terms, the software is intended to help machines adapt to changing conditions and coordinate activity rather than simply follow a fixed sequence. The investment question is whether customers pay for those capabilities repeatedly and at an attractive margin. Source
The business changed materially with the November 14, 2025 acquisitions of GuideTech, Warnke Precision Machining and MKR Fabricators. GuideTech brought aerospace engineering and avionics; the other operations brought manufacturing and fabrication. The June 2026 report records aggregate purchase consideration of approximately $22.6 million, including cash, shares and the initial fair value of contingent consideration. These acquired operations are part of the growth comparison, so the headline increase is not a clean measure of organic software adoption. Source
For the quarter ended June 30, 2026, reported revenue comprised $2.691 million of products, $1.179 million of product-development contracts and $1.913 million of engineering services. The product category included hardware and manufactured components. The same report states that software product revenue had not yet begun. That distinction does not mean the software has no customers or no development funding; it means funded development and commercial software licensing are different revenue sources. Source
The enlarged model has advantages. An engineering team can help integrate software, while manufacturing can turn an opportunity into a physical deliverable. It also makes the company more demanding to finance. Production requires materials, equipment and quality assurance; engineering often requires people before a program produces cash. A software label does not make those obligations disappear.
The first commercial software revenues would therefore be useful evidence, but their size and character would matter. A one-off license associated with integration work would not establish a recurring subscription business. Repeat deployments, customer expansion and a clear contribution to gross profit would be stronger signals. Until then, the most grounded way to follow Palladyne is as a developing defense and industrial supplier with potentially valuable software, rather than assigning all group revenue the economics of a mature software platform.
Palladyne’s revenue reached $5.783 million in the quarter ended June 30, 2026, compared with $1.015 million a year earlier. Using the first half’s $9.321 million and subtracting the June quarter gives a calculated $3.538 million for the March quarter; the sequential increase was approximately 63.5%. These are substantial gains, but management attributes growth to both acquisitions and organic activity. The comparison should retain that qualification. Source Source
The revenue gain did not yet produce operating leverage sufficient to cover the cost base. Operating loss was $13.413 million in the June 2026 quarter versus $8.094 million in the June 2025 quarter. Research and development, sales and marketing, and general and administrative expenses all increased. The growth strategy therefore requires more than a higher sales line: additional gross profit has to outpace the cost of building and supporting the organization. Source
Revenue less the separately reported cost-of-revenue line was a calculated $1.681 million in the June 2026 quarter, or approximately 29.1% of sales, before the separately presented intangible-amortization expense. The calculation is useful for seeing how much revenue remains to fund operating expenses, but it should not be confused with an all-in profitability measure. The acquired mix and the type of contract delivered can move that contribution considerably between quarters. Source
The June 2026 quarterly net loss was $12.326 million, or $0.27 per share, and included a $0.814 million noncash gain from warrant revaluation. Stock compensation was $2.319 million in the same quarter. Management’s adjusted loss removes specified accounting items, but operating cash flow is the more direct test of how much funding the business consumes. An accounting gain on a warrant liability cannot pay an engineer or purchase inventory. Source
What deserves attention in the next results is the combination of revenue mix, cash collection and expenses. More engineering work can support sales without immediately validating software margins. Product deliveries can lift reported revenue while building receivables. Strong bookings can precede the associated expenditure. A useful quarter would explain all three movements instead of relying on the growth percentage alone.
The final June 30, 2026 backlog was $24.6 million. It supersedes the approximately $24 million preliminary figure discussed in July. The final quarterly release also reported approximately $13 million of new contract awards during the June quarter. The company expected most of the backlog to convert to revenue over the following 12–18 months, so it cannot all be treated as revenue due before the end of 2026. Source Source
The definition matters: backlog includes committed contracts and purchase orders, both funded and unfunded, less revenue already recognized. It is a better indication of actual commercial work than a partnership announcement, but it is not a cash balance. Delivery, funding and customer acceptance can affect when the work produces revenue and when that revenue becomes cash. Source
At June 30, 2026, the company’s broader total contract value was $30.9 million, including estimated potential value from unexercised options on existing firm contracts. That figure includes backlog rather than sitting on top of it. Adding the two would double count the contracted base. The extra option value is contingent on future customer decisions; it is not equivalent to a newly exercised order. Source
The August 6 guidance of $24–27 million for full-year 2026, less first-half revenue of $9.321 million, implies second-half revenue of $14.679–17.679 million. Spread evenly, that would be approximately $7.34–8.84 million per quarter, compared with the June quarter’s $5.783 million. This is a calculation illustrating the required pace, not new guidance or a forecast that the quarters will be equal. Source Source
A useful next update would identify which work supports that acceleration and how much depends on new awards. It would also explain whether backlog replenishment keeps up with revenue recognition. A declining backlog can be healthy when deliveries accelerate, but it becomes a concern if replacement orders weaken at the same time. Conversely, a higher backlog is less reassuring if conversion repeatedly slips and working capital absorbs more cash.
The practical test is whether management can connect booked work, expected deliveries and available capacity. This makes an exercised contract option more meaningful than an enlarged addressable market, and makes cash collection more meaningful than simply repeating the total value of a program.
At June 30, 2026, Palladyne reported $33.774 million of cash and cash equivalents and $9.972 million of marketable securities, a combined $43.746 million. The securities were U.S. Treasury securities. The comparable combined balance at December 31, 2025 was $47.055 million. Cash alone rose during the first half partly because securities matured; that internal change does not represent new customer cash generation. Source
For the six months ended June 30, 2026, cash used in operations was $20.401 million and purchases of property and equipment were $0.889 million. Adding those amounts gives $21.290 million, or approximately $3.548 million per month. This uses management’s definition of operating cash burn: operating cash outflow plus capital expenditure. The $0.100 million received from selling equipment is shown separately and has not been used to reduce this calculation. Source Source
Dividing June 30 liquidity of $43.746 million by that historical monthly burn produces approximately 12.3 months of static coverage. The inputs are dated June 2026; the result is not a cash forecast as of October and not an estimated insolvency date. It assumes unchanged spending and collections, no new funding and no other use of capital. A company that is changing its delivery mix can depart materially from those assumptions. Source
The quarterly comparison reinforces why the annual average needs context. March 2026 operating cash use was $10.239 million with $0.027 million of capex, giving $10.266 million of company-defined burn. Subtracting those figures from the first half produces calculated June-quarter burn of $11.024 million, or about $3.675 million per month. Cash consumption increased even as revenue grew. Source Source
Management reiterated full-year 2026 burn guidance of $32–36 million on August 6. After the first half’s calculated $21.290 million, that implies $10.710–14.710 million for the second half, equivalent to approximately $1.785–2.452 million per month. This is the key improvement embedded in the outlook: the second half must consume meaningfully less cash than the first. The company attributed the expected improvement to higher revenue and margins after investment in staff and capacity. Source Source
The June report said resources should support at least the next twelve months from its August 6 filing date. That is management’s forward assessment; the static calculation above is a separate historical sensitivity. The trader should watch the next cash-flow statement for evidence that collections and gross profit are actually reducing funding needs. New equity can preserve the balance even when the underlying burn has not improved.
Palladyne is not carrying the type of large bond maturity that dominates some defense-growth companies. It nevertheless has obligations. At June 30, 2026, the balance sheet reported $1.372 million of noncurrent equipment-financing liabilities, together with $1.196 million of current and $9.361 million of noncurrent operating-lease liabilities. Management’s description of having no significant debt should not be simplified into having no financial commitments. Source
The more immediate funding mechanism is equity. During the first half of 2026, the company sold 2,531,336 shares through its Jefferies ATM program for approximately $17.8 million gross. The June report stated cumulative ATM sales of 10,653,920 shares and approximately $73.3 million gross through the reported period. These are completed sales, not an undrawn credit facility or a promise that the same capital will remain available. Source
An ATM allows issuance into the market over time. Its usefulness depends on the share price, market demand, registration capacity and the terms of the sale program. The company can raise money without negotiating a large single financing, but existing holders own a smaller percentage after new shares are issued. Stable liquidity accompanied by a growing denominator is a different outcome from stable liquidity funded by customer receipts.
The January 9, 2026 resale registration concerned up to 8,365,446 shares associated with the GuideTech transaction, including shares issued at closing and possible earnout shares. The prospectus states that Palladyne would receive no proceeds from selling-stockholder resales. That registration is therefore not additional cash available to finance operations. Potential earnout issuance remains dependent on the contractual conditions and the choice of cash or stock settlement. Source
The acquisition terms summarized in the June 2026 report allow up to $25 million of earnout payments over five years if revenue targets are achieved, payable in cash or shares. Success can thus create an additional claim on cash or an additional source of dilution. It is sensible to judge the value acquired alongside that cost, rather than treating contingent consideration as automatically negative or ignoring it because it is contingent. Source
Current funding depends primarily on equity issuance. Operating progress needs to reduce that dependence; a future borrowing agreement could change both the funding structure and the obligations or covenants shareholders need to monitor. Contract requirements and manufacturing commitments remain relevant even when conventional financial debt is modest. Source
Palladyne had 49,143,403 common shares issued and outstanding at June 30, 2026, up from 46,117,164 at December 31, 2025. The later cover-page count was 49,338,510 at July 29, 2026. The latter is the more recent company-reported count, while neither number should be relabeled as the exact count on October 1. The balance sheet authorized 165 million common shares at June 30; authorization is capacity, not an announcement that all of it will be issued. Source
The legacy deSPAC warrants had a contractual expiration of September 24, 2026 at 5 p.m. New York time. Nasdaq’s September 28 removal notice identifies the warrant security. It does not announce delisting of the PDYN common shares. The expired legacy instrument also should not be carried forward as though it remained an open source of future exercise after its deadline. Source Source
That event did not eliminate all warrant exposure. At June 30, 2026, 430,105 separate warrants from the 2024 insider placement remained outstanding with a $2.30 exercise price and a five-and-a-half-year life from their November 2024 issuance. These are a different instrument from the deSPAC warrants. Any later exercise would need its own evidence; their reported June balance is not a statement that they were all exercised or all extinguished in September. Source
Equity compensation is a larger overhang. At June 30, 2026, reported options totaled 1,092,586 and outstanding RSUs totaled 7,206,072. The RSU total already includes the 2025 executive awards approved by shareholders in June; adding those executive awards again would double count them. The report also listed 1.5 million restricted stock awards. These categories should not be indiscriminately added to the common-share count, because issued restricted shares and rights to future shares are not the same thing. Source
The executive program covers approximately 5.4 million units, subject to market and service conditions. Its price milestones require sustained performance over 60 consecutive trading days, and unmet tranches are forfeited after November 15, 2030. This is potential dilution conditioned on outcomes, not immediate issuance of the headline amount. Expense recognition and eventual settlement also need not occur at the same time. Source
The amended equity plan described in June 2026 allows 9.5 million shares plus qualifying recycled legacy awards, with approximately 5.9 million shares then available for grants. Use that disclosed reserve rather than assuming an unstated automatic annual increase. The economic question is whether growth in the business exceeds growth in the claims on it; a rising revenue chart alone cannot answer that. Source
The September 8, 2026 FANUC America collaboration focuses on adapting Palladyne IQ to FANUC industrial robots and validating customer applications. It offers a route into manufacturing and logistics. The announcement describes development and commercial cooperation, without a quantified purchase commitment or revenue timetable. Its next meaningful financial evidence would be paid adoption and repeat deployment. Source
The August 26, 2026 NORDA agreement concerns planned integration of SwarmOS with NORDA’s Underdog autonomy module and a joint demonstration, subject to required governmental approvals. The parties’ claims about their own technology do not establish the performance or economics of the future combined system. For this hub, the relevant distinction is between an integration program and an order that contributes a specified amount to backlog. Source
Orkid’s August 19, 2026 partnership extends Palladyne Pilot and SwarmOS toward fixed-wing aircraft for defense and industrial applications. Palladyne described it as its first partnership focused on bringing SwarmOS to that aircraft category. The announcement identifies a commercialization route, not a contract value. Broader platform compatibility may help distribution, but integration costs and customer decisions still determine the eventual return. Source
Those collaborations sit beside identifiable funded work. The August 6 results release cited $2.6 million of BRAIN computer orders, including a $2.3 million counter-UAS-related contract; commencement of the previously announced $4.2 million HANGTIME contract; and a $2.9 million STRATFI option exercise that brought that program above $10.6 million. These figures describe different scopes and stages. They should not all be added to the reported June backlog as though every announcement represented newly booked incremental work. Source
The IAI arrangement described in the August 6 release provides exclusive U.S. rights for specified systems, with no upfront payment and up to ten years of exclusivity. Those rights can expand the opportunity set without constituting a government procurement award. The financial progression to watch is customer commitment, manufacturing readiness, delivery obligations and cash collection. A large potential market becomes useful to valuation only when the supplier’s share of that market has credible economics. Source
For an announcement to materially strengthen the thesis, it should reveal more than a partner’s name. The useful details are committed scope, customer funding, delivery timing, expected recognition and the resources needed to perform. A program can be strategically attractive while still increasing near-term burn. Treating every favorable announcement as immediately accretive would miss that tradeoff.
The next financial checkpoint is the report for the quarter ended September 30, 2026. A precise earnings-release date is not established by the cited announcements and is not assigned here. The August 6 outlook expected sequential revenue growth in that quarter and declining burn through the second half. Those are the conditions to test when the results arrive. Source
The revenue question is whether deliveries advance at a pace consistent with the annual outlook. The cash question is whether the reported burn begins to approach the lower pace implied for the second half. The financing question is how much of the cash balance comes from customer receipts and how much comes from additional shares. Read together, those answers show whether a growing order book is producing a more sustainable company.
On August 6, 2026, Palladyne said it had invitations to five further military exercises through March 2027. That is a participation window, not a timetable for five contract awards. Demonstration success can improve access to procurement decisions, while the separate award process and budget determine revenue. Exercises already described as underway in August should not be presented as future events in October. Source
The partnership catalysts are less precisely dated. FANUC customer validation, NORDA integration and approvals, and Orkid deployment work can create useful updates. None of their cited releases supplies a guaranteed date for material revenue. The correct watchpoint is a disclosed milestone with a financial implication, rather than a calendar date inferred from enthusiasm in a press release. Source Source Source
At the next results, the most informative management explanation would connect a specific delivery to recognition, collection and remaining work. If revenue rises but unbilled receivables expand faster, the cash benefit may still lie ahead. If cash improves mainly after an ATM sale, funding risk has been postponed rather than resolved. If software sales emerge, their contract structure and contribution deserve attention before assuming recurring revenue.
Finviz records a Nasdaq closing price of $5.16 for September 30, 2026. Finviz’s October 1 capture lists a float of 35.03 million shares, short interest equal to 18.41% of float and a short ratio of 6.50. The provider capture does not expose the underlying short-interest settlement date. These are provider fields observed on that date, not proof that the short positions were measured at the September 30 close. Source Source
The short ratio relates reported short shares to the provider’s average trading volume. It is not a deadline by which positions must be covered, and it does not reveal borrowing costs or the current availability of shares. A small float and substantial short positioning can intensify a reaction to a real contract or financing surprise in either direction. They do not substitute for the operating evidence.
The same October 1, 2026 Finviz capture reports insider ownership of 29.01% and institutional ownership of 25.80%. These aggregated fields use provider definitions and reporting lags. They should not be used as a complete, simultaneous ownership ledger or mixed with a dated SEC percentage as though every denominator and security definition were identical. Source
A specific insider action is clearer. CEO Benjamin Wolff reported buying 17,121 common shares on September 8, 2026 at a weighted average price of $5.7899 through Mare’s Leg Capital, an entity owned with his spouse. The reported purchase value is approximately $99,100, calculated from those inputs. This was an actual purchase, not a tax-withholding disposal or an award grant. It indicates additional personal exposure, but it cannot validate a future sales forecast. Source
William Kerber’s May 14, 2026 ownership amendment reported 2,366,314 beneficially owned shares and 5.0% using its then-current denominator; it included a May 13 purchase of 10,000 shares and identified transfers to a trust as gifts. Those gifts should not be classified as open-market sales. The April 2026 proxy separately lists BlackRock Portfolio Management with 3,042,065 shares and 6.4% on that proxy’s dated basis. These are identifiable ownership disclosures rather than estimates of their holdings on October 1. Source Source
Ownership matters most when read alongside the share count and compensation structure. Management can increase its exposure while the company also issues new shares to finance operations. Both statements can be true. The relevant question for an outside shareholder remains how much operating value is created for each additional claim on the business.
The main risk is commercialization outrunning financial capacity. Palladyne has expanded its addressable work, but engineering and manufacturing consume resources before the eventual margin is known. A contract that looks attractive at award can produce disappointing cash flow if execution requires more staff, materials or time than anticipated. Fixed-price work is particularly sensitive to that mismatch, while government-funded activity can face changes in scope and timing. Source
The second risk is mistaking corporate growth for progress per share. Acquisitions added real businesses, and the ATM added real cash. They also brought integration costs, contingent consideration and a larger equity base. A favorable operating update should therefore improve the relationship between revenue, cash use and shares, rather than just provide a larger consolidated total.
The third risk is assigning software economics before there is software product revenue. The June 2026 statement of no software product sales is material because it changes the evidence required for the valuation narrative. Paid development is valuable, but repeat commercial licensing would be a different achievement. The thesis strengthens when customer adoption becomes visible in revenue and cash, not merely in the number of cooperating platforms. Source
A final risk is headline classification. A military exercise is not an award, a collaboration is not a quantified order, an option is not exercised backlog, a resale registration does not fund the company, and the removal of an expired warrant does not delist the common stock. Those distinctions determine what an announcement actually changes for a trader.
The practical conclusion is to follow the conversion of existing work into revenue and cash while measuring the financing required to get there. Palladyne has a broader operating base and several credible routes to commercialization. The decisive next evidence is a faster delivery pace with lower burn and manageable dilution. Until those elements improve together, commercial opportunity and financial robustness remain separate questions.
The report for June 30, 2026 states that software product revenue had not yet begun. The group earns revenue from hardware, product-development contracts and engineering services; development funding is different from software product sales. Source
At June 30, 2026 cash plus marketable securities totaled $43.746 million. First-half operating outflow plus capex averaged approximately $3.548 million monthly, giving calculated static coverage of about 12.3 months. This is a historical sensitivity, not a forecast of the cash-exhaustion date. Source
No. The September 28, 2026 Nasdaq notice identifies the warrant security. The legacy deSPAC warrants had a September 24 expiration; common shares and the separate 2024 insider warrants are different securities. Source Source
The September 8, 2026 release describes collaboration and customer validation, without a quantified purchase commitment. Commercial adoption must be assessed through subsequent customer evidence. Source
No. The $24.6 million June 30, 2026 backlog includes funded and unfunded commitments, with most expected to convert over the following 12–18 months. It is not all revenue due in 2026 or cash already received. Source
Yes. Wolff’s Form 4 reports 17,121 shares bought on September 8, 2026 at a weighted average $5.7899 through Mare’s Leg Capital. The transaction is distinct from equity compensation or tax withholding. Source
Every Merlintrader stock hub, catalyst update and market brief is published to Telegram the moment it goes live. No paywall, no spam, just the research.
Disclaimer. This content is published by Merlintrader for educational and informational purposes only. It is independent journalism and research. It does not constitute investment advice, an investment recommendation, an offer or a solicitation to buy or sell any security, and it is not a research report within the meaning of applicable United States securities regulation. Nothing here should be read as a recommendation to buy, sell or hold $PDYN or any other security.
Figures are taken from public filings with the U.S. Securities and Exchange Commission, company press releases and market-data providers, and are stated with their reference dates. Data can change without notice, and figures published before a results release become outdated the moment that release is issued. Merlintrader makes no representation that the information is complete or current at the time of reading. Readers should verify every figure against the primary source before acting on it.
Defense, space and technology companies carry procurement, execution, regulatory and financing risks. Government orders can be delayed or cancelled, production can exceed budget, export restrictions can limit sales, and acquisitions may fail to produce the expected returns. Contract announcements do not guarantee profitable deliveries or cash collection. Additional borrowing or equity issuance can increase obligations or dilute existing shareholders. Investors can lose part or all of their capital. Every reader is responsible for their own decisions and should consult a licensed financial adviser where appropriate.
Merlintrader may hold positions in securities mentioned. Some links on this page are affiliate or referral links, including those to Finviz and Stocktwits, which may generate a commission at no cost to the reader. Full legal information is available on the disclaimer and terms of use and privacy pages.
Conferences, industry summits, government-facing events and company watchpoints across the sector, in one free calendar.
Open the Space, Defense & AI Event Calendar →